- Home
- ALBT
as 03-28-2025 4:00pm EST
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | FREEHOLD |
| Market Cap: | 7.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 111.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -18.76 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.11 - $21.60 | Next Earning Date: | 04-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Avalon GloboCare Corp. News
ALBT Breaking Stock News: Dive into ALBT Ticker-Specific Updates for Smart Investing
GlobeNewswire
21 days ago
Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement
GlobeNewswire
a month ago
Fusion Fuel Appoints Luisa Ingargiola to Board of Directors
MT Newswires
a month ago
Avalon GloboCare Receives Notice of Allowance for Chimeric Antigen Receptor Cell Technology in China
GlobeNewswire
a month ago
Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China
MT Newswires
3 months ago
Avalon GloboCare Pockets $3.5 Million After Initial Close of Preferred Stock Sale -- Common Shares Slump
GlobeNewswire
4 months ago
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements
GlobeNewswire
4 months ago
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device
Simply Wall St.
4 months ago
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023)
Compare ALBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALBT Avalon GloboCare Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.